MM, G., L, B., T, B., AD, W., L, K., J, R., . . . JC, T. (2021). Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016). Annals of surgical oncology, 28(13), 8651. https://doi.org/10.1245/s10434-021-10287-5
Chicago Style (17th ed.) CitationMM, Goldbach, Burkbauer L, Bharani T, Williams AD, Keele L, Rothman J, Jankowitz R, and Tchou JC. "Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016)." Annals of Surgical Oncology 28, no. 13 (2021): 8651. https://doi.org/10.1245/s10434-021-10287-5.
MLA (9th ed.) CitationMM, Goldbach, et al. "Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016)." Annals of Surgical Oncology, vol. 28, no. 13, 2021, p. 8651, https://doi.org/10.1245/s10434-021-10287-5.